Global Psoriatic Arthritis Drugs Market Research Report 2021
Table of Contents1 Psoriatic Arthritis Drugs Market Overview
1.1 Product Overview and Scope of Psoriatic Arthritis Drugs
1.2 Psoriatic Arthritis Drugs Segment by Type
1.2.1 Global Psoriatic Arthritis Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Other
1.3 Psoriatic Arthritis Drugs Segment by Application
1.3.1 Psoriatic Arthritis Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Mild Psoriatic Arthritis
1.3.3 Moderate Psoriatic Arthritis
1.3.4 Severe Psoriatic Arthritis
1.4 Global Psoriatic Arthritis Drugs Market Size Estimates and Forecasts
1.4.1 Global Psoriatic Arthritis Drugs Revenue 2016-2027
1.4.2 Global Psoriatic Arthritis Drugs Sales 2016-2027
1.4.3 Psoriatic Arthritis Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Psoriatic Arthritis Drugs Market Competition by Manufacturers
2.1 Global Psoriatic Arthritis Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Psoriatic Arthritis Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Psoriatic Arthritis Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Psoriatic Arthritis Drugs Manufacturing Sites, Area Served, Product Type
2.5 Psoriatic Arthritis Drugs Market Competitive Situation and Trends
2.5.1 Psoriatic Arthritis Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Psoriatic Arthritis Drugs Players Market Share by Revenue
2.5.3 Global Psoriatic Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Psoriatic Arthritis Drugs Retrospective Market Scenario by Region
3.1 Global Psoriatic Arthritis Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Psoriatic Arthritis Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.3.1 North America Psoriatic Arthritis Drugs Sales by Country
3.3.2 North America Psoriatic Arthritis Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.4.1 Europe Psoriatic Arthritis Drugs Sales by Country
3.4.2 Europe Psoriatic Arthritis Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Psoriatic Arthritis Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Psoriatic Arthritis Drugs Sales by Region
3.5.2 Asia Pacific Psoriatic Arthritis Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.6.1 Latin America Psoriatic Arthritis Drugs Sales by Country
3.6.2 Latin America Psoriatic Arthritis Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Psoriatic Arthritis Drugs Sales by Country
3.7.2 Middle East and Africa Psoriatic Arthritis Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Psoriatic Arthritis Drugs Historic Market Analysis by Type
4.1 Global Psoriatic Arthritis Drugs Sales Market Share by Type (2016-2021)
4.2 Global Psoriatic Arthritis Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Psoriatic Arthritis Drugs Price by Type (2016-2021)
5 Global Psoriatic Arthritis Drugs Historic Market Analysis by Application
5.1 Global Psoriatic Arthritis Drugs Sales Market Share by Application (2016-2021)
5.2 Global Psoriatic Arthritis Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Psoriatic Arthritis Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Abbvie
6.1.1 Abbvie Corporation Information
6.1.2 Abbvie Description and Business Overview
6.1.3 Abbvie Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbvie Product Portfolio
6.1.5 Abbvie Recent Developments/Updates
6.2 Janssen
6.2.1 Janssen Corporation Information
6.2.2 Janssen Description and Business Overview
6.2.3 Janssen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Janssen Product Portfolio
6.2.5 Janssen Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Corporation Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Amgen Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Eli-lilly
6.5.1 Eli-lilly Corporation Information
6.5.2 Eli-lilly Description and Business Overview
6.5.3 Eli-lilly Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Eli-lilly Product Portfolio
6.5.5 Eli-lilly Recent Developments/Updates
6.6 Celgene
6.6.1 Celgene Corporation Information
6.6.2 Celgene Description and Business Overview
6.6.3 Celgene Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Celgene Product Portfolio
6.6.5 Celgene Recent Developments/Updates
7 Psoriatic Arthritis Drugs Manufacturing Cost Analysis
7.1 Psoriatic Arthritis Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Psoriatic Arthritis Drugs
7.4 Psoriatic Arthritis Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Psoriatic Arthritis Drugs Distributors List
8.3 Psoriatic Arthritis Drugs Customers
9 Psoriatic Arthritis Drugs Market Dynamics
9.1 Psoriatic Arthritis Drugs Industry Trends
9.2 Psoriatic Arthritis Drugs Growth Drivers
9.3 Psoriatic Arthritis Drugs Market Challenges
9.4 Psoriatic Arthritis Drugs Market Restraints
10 Global Market Forecast
10.1 Psoriatic Arthritis Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Psoriatic Arthritis Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Psoriatic Arthritis Drugs by Type (2022-2027)
10.2 Psoriatic Arthritis Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Psoriatic Arthritis Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Psoriatic Arthritis Drugs by Application (2022-2027)
10.3 Psoriatic Arthritis Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Psoriatic Arthritis Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Psoriatic Arthritis Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Psoriatic Arthritis Drugs Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Psoriatic Arthritis Drugs Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Psoriatic Arthritis Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Psoriatic Arthritis Drugs Covered in This Study
Table 5. Global Psoriatic Arthritis Drugs Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Psoriatic Arthritis Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Psoriatic Arthritis Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Psoriatic Arthritis Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Psoriatic Arthritis Drugs Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Psoriatic Arthritis Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Psoriatic Arthritis Drugs Product Type
Table 12. Global Psoriatic Arthritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Psoriatic Arthritis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Psoriatic Arthritis Drugs Sales by Region (2016-2021) & (K MT)
Table 16. Global Psoriatic Arthritis Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Psoriatic Arthritis Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Psoriatic Arthritis Drugs Sales by Country (2016-2021) & (K MT)
Table 19. North America Psoriatic Arthritis Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Psoriatic Arthritis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Psoriatic Arthritis Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Psoriatic Arthritis Drugs Sales by Country (2016-2021) & (K MT)
Table 23. Europe Psoriatic Arthritis Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Psoriatic Arthritis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Psoriatic Arthritis Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Psoriatic Arthritis Drugs Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Psoriatic Arthritis Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Psoriatic Arthritis Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Psoriatic Arthritis Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Psoriatic Arthritis Drugs Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Psoriatic Arthritis Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Psoriatic Arthritis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Psoriatic Arthritis Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Psoriatic Arthritis Drugs Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Psoriatic Arthritis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Psoriatic Arthritis Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Psoriatic Arthritis Drugs Sales (K MT) by Type (2016-2021)
Table 39. Global Psoriatic Arthritis Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Psoriatic Arthritis Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Psoriatic Arthritis Drugs Revenue Share by Type (2016-2021)
Table 42. Global Psoriatic Arthritis Drugs Price (USD/MT) by Type (2016-2021)
Table 43. Global Psoriatic Arthritis Drugs Sales (K MT) by Application (2016-2021)
Table 44. Global Psoriatic Arthritis Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Psoriatic Arthritis Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Psoriatic Arthritis Drugs Revenue Share by Application (2016-2021)
Table 47. Global Psoriatic Arthritis Drugs Price (USD/MT) by Application (2016-2021)
Table 48. Abbvie Corporation Information
Table 49. Abbvie Description and Business Overview
Table 50. Abbvie Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Abbvie Psoriatic Arthritis Drugs Product
Table 52. Abbvie Recent Developments/Updates
Table 53. Janssen Corporation Information
Table 54. Janssen Description and Business Overview
Table 55. Janssen Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Janssen Psoriatic Arthritis Drugs Product
Table 57. Janssen Recent Developments/Updates
Table 58. Amgen Corporation Information
Table 59. Amgen Description and Business Overview
Table 60. Amgen Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Amgen Psoriatic Arthritis Drugs Product
Table 62. Amgen Recent Developments/Updates
Table 63. Pfizer Corporation Information
Table 64. Pfizer Description and Business Overview
Table 65. Pfizer Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Pfizer Psoriatic Arthritis Drugs Product
Table 67. Pfizer Recent Developments/Updates
Table 68. Eli-lilly Corporation Information
Table 69. Eli-lilly Description and Business Overview
Table 70. Eli-lilly Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Eli-lilly Psoriatic Arthritis Drugs Product
Table 72. Eli-lilly Recent Developments/Updates
Table 73. Celgene Corporation Information
Table 74. Celgene Description and Business Overview
Table 75. Celgene Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Celgene Psoriatic Arthritis Drugs Product
Table 77. Celgene Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Psoriatic Arthritis Drugs Distributors List
Table 81. Psoriatic Arthritis Drugs Customers List
Table 82. Psoriatic Arthritis Drugs Market Trends
Table 83. Psoriatic Arthritis Drugs Growth Drivers
Table 84. Psoriatic Arthritis Drugs Market Restraints
Table 85. Global Psoriatic Arthritis Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 86. Global Psoriatic Arthritis Drugs Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Psoriatic Arthritis Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Psoriatic Arthritis Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Psoriatic Arthritis Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 90. Global Psoriatic Arthritis Drugs Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Psoriatic Arthritis Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Psoriatic Arthritis Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Psoriatic Arthritis Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 94. Global Psoriatic Arthritis Drugs Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Psoriatic Arthritis Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Psoriatic Arthritis Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Psoriatic Arthritis Drugs
Figure 2. Global Psoriatic Arthritis Drugs Market Share by Type in 2020 & 2027
Figure 3. TNF Inhibitors Product Picture
Figure 4. PDE4 Inhibitors Product Picture
Figure 5. Interleukin Blockers Product Picture
Figure 6. Other Product Picture
Figure 7. Global Psoriatic Arthritis Drugs Market Share by Application in 2020 & 2027
Figure 8. Mild Psoriatic Arthritis
Figure 9. Moderate Psoriatic Arthritis
Figure 10. Severe Psoriatic Arthritis
Figure 11. Global Psoriatic Arthritis Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Psoriatic Arthritis Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Psoriatic Arthritis Drugs Sales 2016-2027 (K MT)
Figure 14. Global Psoriatic Arthritis Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Psoriatic Arthritis Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Psoriatic Arthritis Drugs Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Psoriatic Arthritis Drugs Players: Market Share by Revenue in 2020
Figure 18. Psoriatic Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Psoriatic Arthritis Drugs Sales Market Share by Region (2016-2021)
Figure 20. Global Psoriatic Arthritis Drugs Sales Market Share by Region in 2020
Figure 21. Global Psoriatic Arthritis Drugs Revenue Market Share by Region (2016-2021)
Figure 22. Global Psoriatic Arthritis Drugs Revenue Market Share by Region in 2020
Figure 23. U.S. Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Psoriatic Arthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Psoriatic Arthritis Drugs by Type (2016-2021)
Figure 48. Sales Market Share of Psoriatic Arthritis Drugs by Application (2016-2021)
Figure 49. Sales Market Share of Psoriatic Arthritis Drugs by Application in 2020
Figure 50. Revenue Share of Psoriatic Arthritis Drugs by Application (2016-2021)
Figure 51. Revenue Share of Psoriatic Arthritis Drugs by Application in 2020
Figure 52. Manufacturing Cost Structure of Psoriatic Arthritis Drugs
Figure 53. Manufacturing Process Analysis of Psoriatic Arthritis Drugs
Figure 54. Psoriatic Arthritis Drugs Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed